These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 21634006)

  • 21. Section 2. Small-for-size liver graft and hepatocellular carcinoma recurrence.
    Chan SC
    Transplantation; 2014 Apr; 97 Suppl 8():S7-S10. PubMed ID: 24849840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended criteria for living donor liver transplantation in patients with advanced hepatocellular carcinoma.
    Choi HJ; Kim DG; Na GH; Hong TH; You YK
    Transplant Proc; 2012 Mar; 44(2):399-402. PubMed ID: 22410027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?
    Yao FY; Breitenstein S; Broelsch CE; Dufour JF; Sherman M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S109-16. PubMed ID: 21584927
    [No Abstract]   [Full Text] [Related]  

  • 24. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation.
    Li C; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Wei YG
    Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):366-9. PubMed ID: 20688599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical treatment for hepatocellular carcinoma.
    Takayama T
    Jpn J Clin Oncol; 2011 Apr; 41(4):447-54. PubMed ID: 21411469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series.
    Sugawara Y; Tamura S; Makuuchi M
    Dig Dis; 2007; 25(4):310-2. PubMed ID: 17960065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocellular carcinoma and liver transplantation.
    Washburn K; Halff G
    Curr Opin Organ Transplant; 2011 Jun; 16(3):297-300. PubMed ID: 21505342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement.
    Prasad KR; Young RS; Burra P; Zheng SS; Mazzaferro V; Moon DB; Freeman RB
    Liver Transpl; 2011 Oct; 17 Suppl 2():S81-9. PubMed ID: 21748847
    [No Abstract]   [Full Text] [Related]  

  • 29. Recurrent hepatocellular carcinoma after living donor liver transplantation: a preventable problem or an acceptable risk?
    Sonnenday CJ
    Ann Surg Oncol; 2010 Sep; 17(9):2262-3. PubMed ID: 20431956
    [No Abstract]   [Full Text] [Related]  

  • 30. The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program.
    Nemes B; Gelley F; Piros L; Zádori G; Görög D; Fehérvári I; Kóbori L; Sárváry E; Nagy P; Kiss A; Doros A
    Transplant Proc; 2011 May; 43(4):1272-4. PubMed ID: 21620108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of adult living liver donation in patients with hepatocellular cancer.
    Roberts JP
    Liver Transpl; 2003 Oct; 9(10 Suppl 2):S60-3. PubMed ID: 14528431
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of steatosis donor liver transplantation on hepatocellular carcinoma recurrence: experience at a single institution.
    Teng da H; Zhu ZJ; Zheng H; Deng YL; Sun LY; Pan C; Liu YH; Song HL; Shen ZY
    Hepatogastroenterology; 2012 May; 59(115):858-62. PubMed ID: 22389257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Living donor liver transplantation for hepatocellular carcinoma in patients exceeding the UCSF criteria.
    Fouzas I; Sotiropoulos GC; Lang H; Nadalin S; Beckebaum S; Sgourakis G; Saner FH; Radtke A; Papanikolaou V; Baba HA; Paul A; Broelsch CE; Malagó M
    Transplant Proc; 2008 Nov; 40(9):3185-8. PubMed ID: 19010228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic importance of the gross classification of hepatocellular carcinoma in living donor-related liver transplantation.
    Shirabe K; Aishima S; Taketomi A; Soejima Y; Uchiyama H; Kayashima H; Ninomiya M; Mano Y; Maehara Y
    Br J Surg; 2011 Feb; 98(2):261-7. PubMed ID: 21072849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: the controversies continue.
    Lee HS
    Dig Dis; 2007; 25(4):296-8. PubMed ID: 17960062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Selection criteria decisive in hepatocellular carcinoma].
    Söderdahl G; Eilard MS; Rizell M
    Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1750-3. PubMed ID: 23097883
    [No Abstract]   [Full Text] [Related]  

  • 37. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study on the outcome of patients with hepatocellular carcinoma registered for living donor liver transplantation: how long can they wait?
    Mizuno S; Yokoi H; Shiraki K; Usui M; Sakurai H; Tabata M; Sugimoto K; Takei Y; Yamakado K; Takeda K; Uemoto S; Isaji S
    Transplantation; 2010 Mar; 89(6):650-4. PubMed ID: 20048691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should we expand the criteria for liver transplantation for hepatocellular carcinoma--yes, of course!
    Broelsch CE; Frilling A; Malago M
    J Hepatol; 2005 Oct; 43(4):569-73. PubMed ID: 16120470
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma.
    Shin WY; Suh KS; Lee HW; Kim J; Kim T; Yi NJ; Lee KU
    Liver Transpl; 2010 May; 16(5):678-84. PubMed ID: 20440777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.